SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 42 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,639,423 | +4.7% | 1,495,000 | 0.0% | 0.00% | – |
Q2 2023 | $2,520,331 | -56.4% | 1,495,000 | -50.0% | 0.00% | – |
Q1 2023 | $5,776,414 | -43.7% | 2,990,000 | -45.6% | 0.00% | -100.0% |
Q4 2022 | $10,264,660 | +40.2% | 5,495,000 | +25.0% | 0.00% | 0.0% |
Q3 2022 | $7,324,000 | -36.7% | 4,395,000 | -52.4% | 0.00% | 0.0% |
Q2 2022 | $11,567,000 | -4.5% | 9,235,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $12,109,000 | +95.2% | 9,235,000 | +118.1% | 0.00% | – |
Q4 2021 | $6,202,000 | -1.0% | 4,235,000 | 0.0% | 0.00% | – |
Q3 2021 | $6,263,000 | +12.2% | 4,235,000 | 0.0% | 0.00% | – |
Q2 2021 | $5,582,000 | +0.9% | 4,235,000 | 0.0% | 0.00% | – |
Q1 2021 | $5,532,000 | -62.0% | 4,235,000 | -28.6% | 0.00% | -100.0% |
Q4 2020 | $14,551,000 | +16.3% | 5,935,000 | -1.7% | 0.00% | 0.0% |
Q3 2020 | $12,514,000 | -9.6% | 6,035,000 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $13,850,000 | +9.5% | 6,035,000 | -27.6% | 0.00% | 0.0% |
Q1 2020 | $12,652,000 | -48.1% | 8,335,000 | -33.5% | 0.00% | -33.3% |
Q4 2019 | $24,381,000 | +126.8% | 12,535,000 | +54.1% | 0.00% | +200.0% |
Q3 2019 | $10,748,000 | -58.0% | 8,135,000 | -29.2% | 0.00% | -66.7% |
Q2 2019 | $25,576,000 | +29.0% | 11,490,000 | +4.5% | 0.00% | +50.0% |
Q1 2019 | $19,830,000 | – | 10,990,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 92,999,000 | $138,298,000 | 4.13% |
WOLVERINE ASSET MANAGEMENT LLC | 84,505,000 | $125,210,000 | 1.08% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,000,000 | $29,789,000 | 0.79% |
Verition Fund Management LLC | 27,047,000 | $40,063,000 | 0.35% |
ADVENT CAPITAL MANAGEMENT /DE/ | 7,970,000 | $11,789,000 | 0.22% |
Baker Brothers Advisors | 29,174,000 | $43,167,000 | 0.19% |
Calamos Advisors LLC | 23,631,000 | $35,035,000 | 0.15% |
RWC Asset Management LLP | 2,900,000 | $4,300,000 | 0.13% |
Aequim Alternative Investments LP | 1,957,000 | $2,899,000 | 0.11% |
PALISADE CAPITAL MANAGEMENT, LP | 3,148,000 | $4,666,000 | 0.10% |